CS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.339420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.635800E-01
Normal-vs-Stage2
1.384600E-01
Normal-vs-Stage3
3.538200E-02
Normal-vs-Stage4
5.435700E-02
Stage1-vs-Stage2
2.043000E-01
Stage1-vs-Stage3
3.304000E-02
Stage1-vs-Stage4
1.521370E-01
Stage2-vs-Stage3
9.598400E-02
Stage2-vs-Stage4
7.058400E-01
Stage3-vs-Stage4
3.174800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.477190E-01
Normal-vs-AfricanAmerican
3.265000E-01
Normal-vs-Asian
5.580200E-02
Caucasian-vs-AfricanAmerican
7.065000E-01
Caucasian-vs-Asian
2.271600E-01
AfricanAmerican-vs-Asian
3.101600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.785420E-01
Normal-vs-Female
9.798300E-02
Male-vs-Female
2.277000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.202500E-02
Normal-vs-Age(41-60Yrs)
3.258000E-01
Normal-vs-Age(61-80Yrs)
7.918000E-02
Normal-vs-Age(81-100Yrs)
1.436360E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.239200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.315800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.960000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.998300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.532200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.862200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.931500E-02
Normal-vs-Daily Drinker
7.783900E-02
Normal-vs-Weekly Drinker
1.032570E-01
Normal-vs-Occasional Drinker
2.944200E-01
Normal-vs-Social Drinker
2.107400E-01
Non Drinker-vs-Daily Drinker
7.654000E-01
Non Drinker-vs-Weekly Drinker
7.308000E-01
Non Drinker-vs-Occasional Drinker
2.904300E-02
Non Drinker-vs-Social Drinker
2.222200E-01
Daily Drinker-vs-Weekly Drinker
9.326000E-01
Daily Drinker-vs-Occasional Drinker
6.563600E-02
Daily Drinker-vs-Social Drinker
3.554400E-01
Weekly Drinker-vs-Occasional Drinker
1.167960E-01
Weekly Drinker-vs-Social Drinker
4.568000E-01
Occasional Drinker-vs-Social Drinker
4.471200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.252800E-01
Normal-vs-Grade 2
6.813800E-01
Normal-vs-Grade 3
6.483200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.693000E-01
Grade 1-vs-Grade 3
7.682400E-01
Grade 1-vs-Grade 4
2.252800E-01
Grade 2-vs-Grade 3
4.427200E-01
Grade 2-vs-Grade 4
6.813800E-01
Grade 3-vs-Grade 4
6.483200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.034600E-01
Normal-vs-NonDiabetic
1.081040E-01
Diabetic-vs-NonDiabetic
6.093400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.617000E-01
Normal-vs-NoPancreatitis
9.289700E-02
Pancreatitis-vs-NoPancreatitis
5.169800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.315210E-01
Normal-vs-N1
1.401560E-01
N0-vs-N1
7.154800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.213800E-01
Normal-vs-TP53-NonMutant
2.550600E-01
TP53-Mutant-vs-TP53-NonMutant
5.187400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
